Observational data indicates hormonal replacement therapy increases glaucoma risk in postmenopausal women, suggesting further investigation is needed.
Our data suggests that use of any postmenopausal HRT may increase the glaucoma risk, but in POAG subgroup estrogen-only therapy remained significant. Further research is needed to confirm the associations.
No takes yet. Share an insight, caveat, or question.
Loukovaara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: